We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+25.57%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.4B
AUM Growth
+$5.37B
Cap. Flow
+$508M
Cap. Flow %
2%
Top 10 Hldgs %
19.14%
Holding
1,320
New
149
Increased
490
Reduced
420
Closed
99

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.6M
2
AMZN icon
Amazon
AMZN
+$51.1M
3
EBAY icon
eBay
EBAY
+$50.4M
4
NFLX icon
Netflix
NFLX
+$45.5M
5
RTX icon
RTX Corp
RTX
+$36.9M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$190M
2
MA icon
Mastercard
MA
+$48.9M
3
RTN
Raytheon Company
RTN
+$44.4M
4
PEP icon
PepsiCo
PEP
+$43.1M
5
SPGI icon
S&P Global
SPGI
+$42M

Sector Composition

Rank Sector Weight
1 Technology 28.14%
2 Healthcare 19.28%
3 Consumer Discretionary 11.02%
4 Financials 10.21%
5 Industrials 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLS icon
551
Flowserve
FLS
$8.94B
$5.66M 0.02%
+198,500
New +$5.3M
COF icon
552
Capital One
COF
$128B
$5.58M 0.02%
89,183
-58,007
-39% -$3.61M
LXP icon
553
LXP Industrial Trust
LXP
$3.52B
$5.58M 0.02%
105,681
+21,760
+26% +$1.1M
APLS
554
DELISTED
Apellis Pharmaceuticals
APLS
$5.57M 0.02%
170,634
+10,143
+6% +$326K
WMB icon
555
Williams Companies
WMB
$85.8B
$5.56M 0.02%
292,330
+255,800
+700% +$4.76M
ABEV icon
556
Ambev
ABEV
$47.9B
$5.53M 0.02%
2,093,937
-796,008
-28% -$1.88M
KLAC icon
557
KLA
KLAC
$222B
$5.53M 0.02%
284,290
-76,090
-21% -$1.3M
MAS icon
558
Masco
MAS
$14.3B
$5.51M 0.02%
109,799
-734
-0.7% -$31.8K
JLL icon
559
Jones Lang LaSalle
JLL
$15.8B
$5.49M 0.02%
53,060
+26,600
+101% +$2.74M
WCC
560
WESCO International
WCC
$15.1B
$5.48M 0.02%
156,100
+16,600
+12% +$496K
JCI icon
561
Johnson Controls International
JCI
$85.1B
$5.46M 0.02%
159,860
-264,448
-62% -$8.14M
DNLI icon
562
Denali Therapeutics
DNLI
$3.79B
$5.45M 0.02%
225,190
+37,228
+20% +$875K
FISV
563
Fiserv Inc
FISV
$29.7B
$5.4M 0.02%
55,288
-8,012
-13% -$807K
SO icon
564
Southern Company
SO
$108B
$5.39M 0.02%
103,977
+707
+0.7% +$39.3K
BMCH
565
DELISTED
BMC Stock Holdings, Inc
BMCH
$5.38M 0.02%
213,800
RP
566
DELISTED
RealPage, Inc.
RP
$5.37M 0.02%
82,647
-15,780
-16% -$995K
LYB icon
567
LyondellBasell Industries
LYB
$19.5B
$5.33M 0.02%
81,065
+5,264
+7% +$313K
AFL icon
568
Aflac
AFL
$65.5B
$5.32M 0.02%
147,617
+23,108
+19% +$835K
HRL icon
569
Hormel Foods
HRL
$14.2B
$5.29M 0.02%
109,680
+14,884
+16% +$711K
SABR icon
570
Sabre
SABR
$716M
$5.29M 0.02%
655,800
+326,200
+99% +$2.31M
ONC
571
BeOne Medicines Ltd
ONC
$33.9B
$5.25M 0.02%
27,840
+1,292
+5% +$210K
OVID icon
572
Ovid Therapeutics
OVID
$427M
$5.23M 0.02%
709,950
-106,122
-13% -$496K
EQC
573
DELISTED
Equity Commonwealth
EQC
$5.2M 0.02%
161,519
-12,200
-7% -$403K
WAL icon
574
Western Alliance Bancorporation
WAL
$8.81B
$5.19M 0.02%
137,100
+12,100
+10% +$423K
KURA icon
575
Kura Oncology
KURA
$793M
$5.13M 0.02%
314,871
-11,184
-3% -$161K

Similar funds

Axa's Q2 2020 Portfolio in Review

As of Q2 2020, Axa held 1,320 positions worth $25.4B, up 27% from $20B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q2 2020 filing shows 149 new, 490 increased, 420 reduced and 99 closed positions. Its largest new stake was Exelixis: 820,990 shares worth $19.5M. The largest sale was Linde, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2020 buy was Exelixis: 820,990 shares worth $19.5M.
  • Axa added most to Microsoft in Q2 2020, an estimated $82.6M increase.
  • Axa's biggest Q2 2020 reduction was Linde, cutting an estimated $190M.
  • Axa fully exited Raytheon Company in Q2 2020, selling an estimated $44.4M.
  • Axa's ten largest holdings make up 19% of its $25.4B portfolio in Q2 2020.
  • Axa opened 149 new positions and closed 99 in Q2 2020.
  • Axa's portfolio value rose 27% quarter-over-quarter to $25.4B.

Based on Axa's 13F filing for Q2 2020, filed 14 Aug 2020.